Your session is about to expire
← Back to Search
Early Life Interventions for Sickle Cell Disease
Study Summary
This trial is testing if early intervention can improve health outcomes for children with sickle cell disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am the mother of a baby with sickle cell disease.I am taking medication that can harm a pregnancy.
- Group 1: Breastfeeding Intervention Group
- Group 2: Observation Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the trial include older adults aged 75 and over?
"This medical study requires that participants are between the ages of 18 to 50. However, there are 156 clinical trials available for minors and another 116 studies open to adults over 65 years old."
Are there any available slots for participants in this research study?
"Affirmative, an analysis of clinicaltrials.gov verifies that this research is still recruiting patients. Starting October 10th 2019 and most recently updated on May 11th 2022, it's seeking 30 participants from one medical centre."
How large is the current cohort engaging in this clinical experiment?
"Affirmative. The details hosted on clinicaltrials.gov demonstrate that this medical study, which initially appeared online 10/10/2019, is actively recruiting for 30 participants from one site."
Does this study offer an opportunity for me to join in?
"This investigation is actively seeking 30 individuals with anemia or sickle cell between the ages of 18-50. Applicants must meet a few specific requirements to be considered, such as being a mother of an infant with SCD and residing in Birmingham, AL or its environs."
Share this study with friends
Copy Link
Messenger